| UniProt ID | ILEU_HUMAN | |
|---|---|---|
| UniProt AC | P30740 | |
| Protein Name | Leukocyte elastase inhibitor | |
| Gene Name | SERPINB1 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 379 | |
| Subcellular Localization | Cytoplasm. Cytoplasmic granule . | |
| Protein Description | Regulates the activity of the neutrophil proteases elastase, cathepsin G, proteinase-3, chymase, chymotrypsin, and kallikrein-3. Also functions as a potent intracellular inhibitor of granzyme H.. | |
| Protein Sequence | MEQLSSANTRFALDLFLALSENNPAGNIFISPFSISSAMAMVFLGTRGNTAAQLSKTFHFNTVEEVHSRFQSLNADINKRGASYILKLANRLYGEKTYNFLPEFLVSTQKTYGADLASVDFQHASEDARKTINQWVKGQTEGKIPELLASGMVDNMTKLVLVNAIYFKGNWKDKFMKEATTNAPFRLNKKDRKTVKMMYQKKKFAYGYIEDLKCRVLELPYQGEELSMVILLPDDIEDESTGLKKIEEQLTLEKLHEWTKPENLDFIEVNVSLPRFKLEESYTLNSDLARLGVQDLFNSSKADLSGMSGARDIFISKIVHKSFVEVNEEGTEAAAATAGIATFCMLMPEENFTADHPFLFFIRHNSSGSILFLGRFSSP | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 1 | Sulfoxidation | -------MEQLSSAN -------CHHHHCHH | 7.17 | 28465586 | |
| 1 | Acetylation | -------MEQLSSAN -------CHHHHCHH | 7.17 | 22814378 | |
| 26 | Ubiquitination | LSENNPAGNIFISPF HHCCCCCCCEEECCC | 29.08 | - | |
| 45 | Ubiquitination | AMAMVFLGTRGNTAA HHHHHHHCCCCCHHH | 11.25 | - | |
| 62 | Phosphorylation | SKTFHFNTVEEVHSR HHHCCCCCHHHHHHH | 28.49 | 23312004 | |
| 72 | Phosphorylation | EVHSRFQSLNADINK HHHHHHHHHCCCHHH | 22.37 | 20873877 | |
| 79 | 2-Hydroxyisobutyrylation | SLNADINKRGASYIL HHCCCHHHHHHHHHH | 53.17 | - | |
| 79 | Ubiquitination | SLNADINKRGASYIL HHCCCHHHHHHHHHH | 53.17 | - | |
| 79 | Acetylation | SLNADINKRGASYIL HHCCCHHHHHHHHHH | 53.17 | 26051181 | |
| 83 | Phosphorylation | DINKRGASYILKLAN CHHHHHHHHHHHHHH | 18.61 | 22210691 | |
| 84 | Phosphorylation | INKRGASYILKLANR HHHHHHHHHHHHHHH | 15.11 | 23312004 | |
| 87 | Acetylation | RGASYILKLANRLYG HHHHHHHHHHHHHHC | 35.67 | 26051181 | |
| 97 | Phosphorylation | NRLYGEKTYNFLPEF HHHHCCCCCCCCCHH | 21.28 | - | |
| 110 | Ubiquitination | EFLVSTQKTYGADLA HHHHCCCCCCCCCHH | 43.75 | - | |
| 130 | Ubiquitination | HASEDARKTINQWVK CCCHHHHHHHHHHHH | 56.32 | - | |
| 131 | Phosphorylation | ASEDARKTINQWVKG CCHHHHHHHHHHHHC | 21.43 | - | |
| 137 | Acetylation | KTINQWVKGQTEGKI HHHHHHHHCCCCCCH | 42.20 | 19608861 | |
| 137 | Ubiquitination | KTINQWVKGQTEGKI HHHHHHHHCCCCCCH | 42.20 | 19608861 | |
| 143 | Ubiquitination | VKGQTEGKIPELLAS HHCCCCCCHHHHHHH | 49.18 | - | |
| 150 | Ubiquitination | KIPELLASGMVDNMT CHHHHHHHCCCCHHH | 27.65 | - | |
| 150 | Phosphorylation | KIPELLASGMVDNMT CHHHHHHHCCCCHHH | 27.65 | 20068231 | |
| 166 | Phosphorylation | LVLVNAIYFKGNWKD HHEEEEEEECCCCHH | 9.23 | 27259358 | |
| 177 | Acetylation | NWKDKFMKEATTNAP CCHHHHHHHHHCCCC | 47.53 | 19608861 | |
| 177 | Ubiquitination | NWKDKFMKEATTNAP CCHHHHHHHHHCCCC | 47.53 | 21890473 | |
| 177 | Ubiquitination | NWKDKFMKEATTNAP CCHHHHHHHHHCCCC | 47.53 | 21890473 | |
| 177 | Ubiquitination | NWKDKFMKEATTNAP CCHHHHHHHHHCCCC | 47.53 | 21890473 | |
| 196 | Ubiquitination | KKDRKTVKMMYQKKK HHCHHHHHHHHCHHC | 24.15 | 21890473 | |
| 196 | Ubiquitination | KKDRKTVKMMYQKKK HHCHHHHHHHHCHHC | 24.15 | 21890473 | |
| 196 | Ubiquitination | KKDRKTVKMMYQKKK HHCHHHHHHHHCHHC | 24.15 | 21890473 | |
| 196 | Acetylation | KKDRKTVKMMYQKKK HHCHHHHHHHHCHHC | 24.15 | 27178108 | |
| 203 | Ubiquitination | KMMYQKKKFAYGYIE HHHHCHHCHHHHHHC | 42.11 | - | |
| 203 | 2-Hydroxyisobutyrylation | KMMYQKKKFAYGYIE HHHHCHHCHHHHHHC | 42.11 | - | |
| 208 | Phosphorylation | KKKFAYGYIEDLKCR HHCHHHHHHCCCEEE | 6.61 | - | |
| 213 | 2-Hydroxyisobutyrylation | YGYIEDLKCRVLELP HHHHCCCEEEEEECC | 32.11 | - | |
| 245 | Ubiquitination | DESTGLKKIEEQLTL CCCCCHHHHHHHHCH | 61.46 | - | |
| 272 | Phosphorylation | DFIEVNVSLPRFKLE CEEEEECCCCCEECE | 27.70 | 24719451 | |
| 277 | Acetylation | NVSLPRFKLEESYTL ECCCCCEECEECEEC | 57.16 | 26051181 | |
| 282 | Phosphorylation | RFKLEESYTLNSDLA CEECEECEECCHHHH | 20.66 | 17924679 | |
| 286 | Phosphorylation | EESYTLNSDLARLGV EECEECCHHHHHHCH | 36.79 | 17924679 | |
| 299 | Phosphorylation | GVQDLFNSSKADLSG CHHHHHHCCCHHHCC | 26.36 | 28450419 | |
| 300 | Phosphorylation | VQDLFNSSKADLSGM HHHHHHCCCHHHCCC | 32.73 | 25159151 | |
| 301 | Ubiquitination | QDLFNSSKADLSGMS HHHHHCCCHHHCCCC | 45.82 | 21890473 | |
| 307 | Sulfoxidation | SKADLSGMSGARDIF CCHHHCCCCCCHHHH | 2.76 | 30846556 | |
| 317 | Ubiquitination | ARDIFISKIVHKSFV CHHHHHHHHHHHHHE | 43.88 | - | |
| 317 | 2-Hydroxyisobutyrylation | ARDIFISKIVHKSFV CHHHHHHHHHHHHHE | 43.88 | - | |
| 317 | Acetylation | ARDIFISKIVHKSFV CHHHHHHHHHHHHHE | 43.88 | 27452117 | |
| 366 | Phosphorylation | LFFIRHNSSGSILFL EEEEEECCCCCEEEE | 29.92 | 23312004 | |
| 367 | Phosphorylation | FFIRHNSSGSILFLG EEEEECCCCCEEEEE | 41.71 | 28348404 | |
| 369 | Phosphorylation | IRHNSSGSILFLGRF EEECCCCCEEEEEEE | 20.33 | 28348404 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of ILEU_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of ILEU_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ILEU_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| ITPA_HUMAN | ITPA | physical | 26344197 | |
| TES_HUMAN | TES | physical | 26344197 | |
| TPPC4_HUMAN | TRAPPC4 | physical | 26344197 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Exploring proteomes and analyzing protein processing by massspectrometric identification of sorted N-terminal peptides."; Gevaert K., Goethals M., Martens L., Van Damme J., Staes A.,Thomas G.R., Vandekerckhove J.; Nat. Biotechnol. 21:566-569(2003). Cited for: PROTEIN SEQUENCE OF 1-10, AND ACETYLATION AT MET-1. | |
| "Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-137 AND LYS-177, AND MASSSPECTROMETRY. | |
| Phosphorylation | |
| Reference | PubMed |
| "Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra."; Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.; J. Proteome Res. 6:4150-4162(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-282 AND SER-286, ANDMASS SPECTROMETRY. | |